REQUEST A DEMO
Total
USD $0.00
Search more companies

Advance Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Advance Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Advance Pharma Sdn. Bhd. is an enterprise in Malaysia, with the main office in Puchong. The company operates in the Pharmacies and Drug Stores sector. It was first established on February 21, 2001. The company’s latest financial report indicates a net sales revenue increase of 58.13% in 2023. There was a total growth of 17.59% in Advance Pharma Sdn. Bhd.’s total assets over the same period. The net profit margin of Advance Pharma Sdn. Bhd. increased by 16.16% in 2023.

Headquarters
No 28, Jalan Bp 6/6, Bandar Bukit Puchong
Puchong; Selangor; Postal Code: 47120

Contact Details: Purchase the Advance Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Advance Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Advance Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Advance Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
February 21, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Advance Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
58.13%
Total operating revenue
58.13%
Operating profit (EBIT)
598.82%
EBITDA
593.78%
Net Profit (Loss) for the Period
515.67%
Total assets
17.59%
Total equity
15.58%
Operating Profit Margin (ROS)
21.56%
Net Profit Margin
16.16%
Return on Equity (ROE)
14.22%
Quick Ratio
0.13%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?